Compare Smith & Nephew plc (SNN) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Vanguard Short Term Corporate Bond ETF — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Vanguard Short Term Corporate Bond ETF trades at $78.58. The key difference: Smith & Nephew plc pays a 2.57% dividend while Vanguard Short Term Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| SNN | VCSH | |
|---|---|---|
Market Cap | $12.64B | — |
Sector | Health | Fixed Income |
52-Week High | $38.70 | $80.20 |
52-Week Low | $28.73 | $78.45 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VCSH trades at $78.64, down 0.1% on the day, with a bearish technical signal driven by moving averages. The ETF maintains a steady dividend payout, with recent distributions of $0.29-$0.30 per share. News highlights institutional activity, including Allspring Global Investments purchasing 1.47 million shares in July 2026. The fund's focus on short-term corporate bonds offers a higher yield compared to treasury alternatives, though it carries greater credit risk.
The outlook for VCSH is mixed, balancing income appeal against interest rate sensitivity. Opportunities include attractive yield and low expense ratio, while risks involve Fed policy uncertainty and credit spread volatility. Investors seeking short-duration corporate exposure may find value, but should monitor rate expectations and economic conditions closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
